These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7193031)

  • 1. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
    Somani P
    Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.
    Somani P; di Giorgi S
    Chest; 1980 Oct; 78(4):658-60. PubMed ID: 7418495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
    Solti F; Czakó E; Szatmáry L
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lorcainide on experimental arrhythmias in comparison with other antiarrhythmic agents].
    Ma X; Li ZW
    Yao Xue Xue Bao; 1986 Apr; 21(4):241-5. PubMed ID: 3788590
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA; Keefe DL; Rodriguez I; Kates RE
    Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
    Breithardt G; Seipel L; Abendroth RR
    Z Kardiol; 1981 Jul; 70(7):530-5. PubMed ID: 7269732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
    S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorcainide -- an anti-arrhythmic agent for ventricular arrhythmias.
    Myburgh DP; Goldman AP; Schamroth JM
    S Afr Med J; 1980 Feb; 57(7):236-9. PubMed ID: 7404136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effect of lorcainide in patients taking digoxin.
    Giardina EG; Raby K; Saroff AL; Louie-Chu M
    J Clin Pharmacol; 1987; 27(5):378-83. PubMed ID: 3693581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and antiarrhythmic effect of lorcainide.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary clinical and experimental data on a new anti-arrhythmic drug: lorcainide].
    Pretolani E; Battistini G; Iosa G; Mambelli M; Pigini G; Zoli I
    Minerva Med; 1980 Apr; 71(13):975-80. PubMed ID: 7375011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lorcainide in stable ventricular extrasystole. A double-blind study with 48-hour continuous ECG recording].
    Buss J; Stegaru B; Geiger S; Gores D; Heene DL
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1829-32. PubMed ID: 6209080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
    G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lorcainide therapy for symptomatic premature ventricular complexes: efficacy, pharmacokinetics and evidence for norlorcainide antiarrhythmic effect.
    Mead RH; Keefe DL; Kates RE; Winkle RA
    Am J Cardiol; 1985 Jan; 55(1):72-8. PubMed ID: 2578245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.